Viral infectious complementary-DNA studies may identify nonviral genes critical to central nervous system disease.
A major interest of modern science and medicine is the delineation of genes that cause disease. In the case of cancer, the study of viral oncogenic genes led to the recognition of similar human genes that play an important role in this disease. In an analogous fashion, the identification of viral genes important in central nervous system disease may lead to the recognition of related cellular genes that are important in nonviral central nervous system disease. New molecular techniques now provide tools for identification of pathogenic viral genes and elucidation of mechanisms of disease production. Positive-strand RNA viruses such as picornaviruses provide an especially attractive model system for studies of central nervous system disease-producing genes. A limitation in molecular studies of these viruses has resulted from an inability to use restriction enzymes, since these enzymes are active against DNA and not RNA. This limitation has recently been overcome with the preparation of infectious picornavirus complementary-DNA. This review highlights the importance of infectious complementary-DNA in pathogenesis studies and provides a glimpse of the impact of such studies on neurology.
Ohara
Y
Y
Department of Neurology, University of Chicago Pritzker School of Medicine, IL.
Roos
R P
RP
D004247:DNA; D006801:Humans; D009422:Nervous System Diseases / Q000235:genetics*; D017955:Poliovirus / Q000235:genetics*; D012328:RNA Viruses / Q000235:genetics*; D014777:Virus Diseases / Q000235:genetics*
D004247:DNA